Respuesta :
The nurse should discontinue heparin therapy.
Alternative anticoagulants, often a direct thrombin inhibitor, should be used to treat patients with heparin-induced thrombocytopenia since they are at high risk for thrombotic events (DTI).
Heparin typically inhibits clotting and has no effect on platelets, which are elements of the blood that aid in the formation of blood clots. Heparin-induced thrombocytopenia results in a low platelet count because it is brought on by the immune system in reaction to heparin during heparin therapy (thrombocytopenia).
Heparin-induced thrombocytopenia can be either immune-mediated or nonimmune-mediated. The most common type of Heparin-induced thrombocytopenia, known as nonimmune Heparin-induced thrombocytopenia, is benign and is characterized by a little drop in platelet count. Although it happens considerably less frequently, immune-mediated Heparin-induced thrombocytopenia is hazardous. Heparin-induced thrombocytopenia that is immune-mediated significantly reduces platelet numbers. Paradoxically, people with Heparin-induced thrombocytopenia are at risk for serious clotting issues while having a very low platelet count.
To learn more about Heparin-induced thrombocytopenia click here,
https://brainly.com/question/4554279
#SPJ4
